Patents by Inventor Virginia E. Paton

Virginia E. Paton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment with anti-ErbB2 antibodies
    Patent number: 7892549
    Abstract: The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a combination of an anti-ErbB2 antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin.
    Type: Grant
    Filed: February 3, 2003
    Date of Patent: February 22, 2011
    Assignee: Genentech, Inc.
    Inventors: Virginia E. Paton, Steven Shak, Susan D. Hellmann
  • Treatment with anti-ErbB2 antibodies
    Publication number: 20040037823
    Abstract: The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a combination of an anti-ErbB2 antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin.
    Type: Application
    Filed: February 3, 2003
    Publication date: February 26, 2004
    Applicant: Genentech, Inc.
    Inventors: Virginia E. Paton, Steven Shak, Susan D. Hellmann
  • Treatment with anti-ErbB2 antibodies
    Publication number: 20030147884
    Abstract: The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a combination of an anti-ErbB2 antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin.
    Type: Application
    Filed: February 3, 2003
    Publication date: August 7, 2003
    Applicant: Genentech, Inc.
    Inventors: Virginia E. Paton, Steven Shak, Susan D. Hellmann